Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Dare Bioscience (DARE) News Today

Dare Bioscience logo
$2.08 -0.04 (-1.89%)
Closing price 04:00 PM Eastern
Extended Trading
$2.13 +0.05 (+2.64%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

DARE Latest News

Brokers Issue Forecasts for Dare Bioscience Q3 Earnings
August 23 at 2:44 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30292284
Analysts Offer Predictions for Dare Bioscience Q3 Earnings
August 22 at 2:45 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30290582
Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript
August 16, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/dar%C3%A9-bioscience-inc-nasdaqdare-q2-2025-earnings-call-transcript/ar-AA1KDn7G
Dare Bioscience (NASDAQ:DARE) Upgraded to "Hold" at Wall Street Zen
August 16, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30279126
Daré Bioscience Announces Q2 2025 Financial Results
August 15, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/dar%C3%A9-bioscience-announces-q2-2025-financial-results/ar-AA1KzmJU
Daré Bioscience, Inc.: Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 15, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-08/66189345-dare-bioscience-inc-dare-bioscience-reports-second-quarter-2025-financial-results-and-provides-corporate-update-399.htm
Daré Bioscience targets Q4 2025 launch for DARE to PLAY Sildenafil cream while advancing dual-path strategy
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/dar%C3%A9-bioscience-targets-q4-2025-launch-for-dare-to-play-sildenafil-cream-while-advancing-dual-path-strategy/ar-AA1Kycsn
Daré Bioscience, Inc. (DARE) Q2 2025 Earnings Call Transcript
August 14, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4813864-dare-bioscience-inc-dare-q2-2025-earnings-call-transcript
Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/14/3133824/30757/en/dar%c3%a9-bioscience-reports-second-quarter-2025-financial-results-and-provides-corporate-update.html
A Preview Of Dare Bioscience's Earnings
August 13, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/08/47097234/a-preview-of-dare-biosciences-earnings
Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
August 7, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/08/07/3129158/30757/en/dar%c3%a9-bioscience-to-host-second-quarter-2025-financial-results-and-company-update-conference-call-and-webcast-on-august-14-2025.html
Daré Bioscience, Inc.: Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil Cream
July 29, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/66026521-dare-bioscience-inc-dare-bioscience-and-rosy-wellness-launch-first-phase-of-patient-focused-campaign-to-support-dare-to-play-sildenafil-cream-399.htm
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
July 29, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/dar-bioscience-rosy-wellness-launch-120000538.html
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
July 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/29/3123159/30757/en/dar%c3%a9-bioscience-and-rosy-wellness-launch-first-phase-of-patient-focused-campaign-to-support-dare-to-play-sildenafil-cream.html
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
July 21, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/21/3118956/30757/en/update-dar%c3%a9-bioscience-to-host-august-6-webinar-the-dare-to-play-difference-the-sildenafil-cream-that-raises-the-bar.html
Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
July 21, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/dar-bioscience-host-august-6-120000661.html
Daré Bioscience, Inc.: Positive Interim Phase 3 Results Highlight Potential of Ovaprene, Novel Hormone-Free Contraceptive
July 15, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65898778-dare-bioscience-inc-positive-interim-phase-3-results-highlight-potential-of-ovaprene-novel-hormone-free-contraceptive-399.htm
Dare Bioscience Analyst Ratings and Price Targets | NASDAQ:DARE | Benzinga
July 15, 2025  |  benzinga.comhttps://www.benzinga.com/quote/DARE/analyst-ratings
Daré Bioscience Shares Soar on Data From Phase 3 Contraceptive Study
July 15, 2025  |  marketwatch.comhttps://www.marketwatch.com/story/dare-bioscience-shares-soar-on-data-from-phase-3-contraceptive-study-6c0228dd
Crude Oil Moves Lower; Daré Bioscience Shares Jump
July 14, 2025  |  benzinga.comhttps://www.benzinga.com/markets/market-summary/25/07/46399310/crude-oil-moves-lower-dare-bioscience-shares-jump?utm_source=snapi
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
July 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/14/3114681/30757/en/positive-interim-phase-3-results-highlight-potential-of-ovaprene-novel-hormone-free-contraceptive.html
Daré Bioscience, Inc.: Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for ...
July 12, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65886326-dare-bioscience-inc-dare-bioscience-receives-dollar-6-million-non-dilutive-grant-installment-dollar-37-8m-to-date-of-up-to-dollar-49m-commitment-supporting-smart-dr-399.htm
Daré Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders
July 11, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/11/3113952/30757/en/dar%c3%a9-bioscience-receives-6-million-non-dilutive-grant-installment-37-8m-to-date-of-up-to-49m-commitment-supporting-smart-drug-delivery-device-for-contraception-platform-has-broader.html
DARE Daré Bioscience, Inc. - Seeking Alpha
July 3, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/DARE
Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders
June 12, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/06/12/3098753/30757/en/dar%c3%a9-bioscience-announces-adjournment-of-annual-meeting-of-stockholders.html
Daré Bioscience, Inc.: Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
May 17, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-05/65397306-dare-bioscience-inc-dare-bioscience-reports-first-quarter-2025-financial-results-and-provides-company-update-399.htm
Q1 2025 Dare Bioscience Inc Earnings Call
May 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/q1-2025-dare-bioscience-inc-165311919.html
Daré Bioscience outlines $4.5B hormone therapy market entry and expects Q4 2025 revenue as dual path strategy expands
May 14, 2025  |  seekingalpha.comhttps://seekingalpha.com/news/4447685-dare-outlines-expanded-dual-path-strategy-targeting-4_5b-hormone-therapy-market-while
Daré Bioscience, Inc. (DARE) Q1 2025 Earnings Call Transcript
May 13, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4786401-dare-bioscience-inc-dare-q1-2025-earnings-call-transcript
Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
May 13, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/13/3080615/30757/en/dar%c3%a9-bioscience-reports-first-quarter-2025-financial-results-and-provides-company-update.html
Dare Bioscience's Earnings Outlook
May 12, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/05/45359473/dare-biosciences-earnings-outlook
Drug Development Is Slowing Down After Cuts at the FDA
April 17, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/drug-development-is-slowing-down-after-cuts-at-the-fda/ar-AA1D5JTZ
Dare Bioscience to present on expanded business strategy at Jones Conference
April 8, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/dare-bioscience-to-present-on-expanded-business-strategy-at-jones-conference-1034556919
Maxim Group Keeps Their Hold Rating on Daré Bioscience (DARE)
April 5, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/maxim-group-keeps-their-hold-rating-on-dar-bioscience-dare-1034552094
Q4 2024 Dare Bioscience Inc Earnings Call
April 1, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/q4-2024-dare-bioscience-inc-135611996.html
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript
April 1, 2025  |  msn.comhttps://www.msn.com/en-us/health/medical/dar%C3%A9-bioscience-inc-nasdaqdare-q4-2024-earnings-call-transcript/ar-AA1C4lma
Dare Bioscience expects to start recording revenue, cash flow in Q425
April 1, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/dare-bioscience-expects-to-start-recording-revenue-cash-flow-in-q425-1034534560
Daré Bioscience targets Q4 2025 for Sildenafil Cream launch via 503B compounding
March 31, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/dar%C3%A9-bioscience-targets-q4-2025-for-sildenafil-cream-launch-via-503b-compounding/ar-AA1C2sZA
Daré Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript
March 31, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4772096-dare-bioscience-inc-dare-q4-2024-earnings-call-transcript
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
March 31, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/31/3052743/30757/en/dar%c3%a9-bioscience-reports-full-year-2024-financial-results-and-provides-company-update.html
Dare Bioscience Q4 2024 Earnings Preview
March 30, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/dare-bioscience-q4-2024-earnings-preview/ar-AA1BXwku
A Look Ahead: Dare Bioscience's Earnings Forecast
March 28, 2025  |  benzinga.comhttps://www.benzinga.com/insights/earnings/25/03/44536846/a-look-ahead-dare-biosciences-earnings-forecast
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025
March 24, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/24/3047785/30757/en/dar%c3%a9-bioscience-to-host-full-year-2024-financial-results-and-company-update-conference-call-and-webcast-on-march-31-2025.html
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
February 20, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/dar-bioscience-theramex-announce-co-130000792.html
Dare Bioscience risks Nasdaq delisting over market value
February 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/dare-bioscience-risks-nasdaq-delisting-over-market-value/ar-AA1z5red
Dare Bioscience secures additional NIAID funding for HPV treatment
February 6, 2025  |  msn.comhttps://www.msn.com/en-us/science/biology/dare-bioscience-secures-additional-niaid-funding-for-hpv-treatment/ar-AA1yx2cg
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/06/3021978/30757/en/dar%c3%a9-bioscience-announces-funding-award-notice-from-the-national-institutes-of-health-nih-national-institute-of-allergy-and-infectious-diseases-niaid-to-support-dare-hpv-developmen.html
Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/dar%C3%A9-bioscience-to-participate-in-the-women-s-health-series-at-the-43rd-annual-j-p-morgan-healthcare-conference-1034209832
Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/01/09/3007013/30757/en/dar%c3%a9-bioscience-to-participate-in-the-women-s-health-series-at-the-43rd-annual-j-p-morgan-healthcare-conference.html
Optimistic Buy Rating for Daré Bioscience Driven by Strategic Progress and Financial Position
December 18, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/optimistic-buy-rating-for-daré-bioscience-driven-by-strategic-progress-and-financial-position-1034145931
Get Dare Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.

DARE Media Mentions By Week

DARE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DARE
News Sentiment
▼
0.62

0.70
▲
Average
Medical
News Sentiment

DARE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DARE Articles
This Week
▼
16

1
▲
DARE Articles
Average Week

Get Dare Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:DARE) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel